Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IsoPlexis Corporation (ISO : NSDQ)
 
 • Company Description   
IsoPlexis Corporation is a life science technology company which build solutions for development of curative medicines and personalized therapeutics. IsoPlexis Corporation is based in BRANFORD, Conn.

Number of Employees: 386

 
 • Price / Volume Information   
Yesterday's Closing Price: $10.37 Daily Weekly Monthly
20 Day Moving Average: 136,137 shares
Shares Outstanding: 38.96 (millions)
Market Capitalization: $403.96 (millions)
Beta:
52 Week High: $16.95
52 Week Low: $8.65
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -25.98% -23.67%
12 Week % %
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
35 NE INDUSTRIAL ROAD
-
BRANFORD,CT 06405
USA
ph: 475-221-8402
fax: -
None http://isoplexis.com
 
 • General Corporate Information   
Officers
Sean Mackay - Chief Executive Officer
John G. Conley - Chairman
John Strahley - Chief Financial Officer
Michael Egholm - Director
James R. Heath - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: -
Sector: -
CUSIP: 465005106
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/09/22
Share - Related Items
Shares Outstanding: 38.96
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $403.96 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.65 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.27 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
09/30/21 - -
06/30/21 - -
03/31/21 - -
ROA
09/30/21 - -
06/30/21 - -
03/31/21 - -
Current Ratio
09/30/21 - -
06/30/21 - -
03/31/21 - -
Quick Ratio
09/30/21 - -
06/30/21 - -
03/31/21 - -
Operating Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Net Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Pre-Tax Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Book Value
09/30/21 - -
06/30/21 - -
03/31/21 - -
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Capital
09/30/21 - -
06/30/21 - -
03/31/21 - -
 

Powered by Zacks Investment Research ©